Massachusetts

  • September 18, 2026

    DraftKings' Owner Urges PTAB To Invalidate Lutnick's Patent

    The owner of DraftKings has asked the Patent Trial and Appeal Board to invalidate a mobile wagering system patent that lists U.S. Secretary of Commerce Howard Lutnick as its lead inventor.

  • September 18, 2026

    New Balance Wins $58.9M, 3-Year Military Shoe Contract

    The Defense Logistics Agency said it has awarded New Balance Athletics Inc. and San Antonio Shoe Inc. two separate, three-year supply contracts totaling up to $156.9 million to manufacture men's and women's athletic shoes.

  • September 18, 2026

    Universal, Sony Expand IP Battle With AI Music Startup

    Sony Music Entertainment and Universal Music Group launched a new suit against artificial intelligence company Suno Inc. on Friday after they discovered "millions" of copyrighted songs in the training data for an AI song generator, but were not permitted by a judge to add the works to an existing lawsuit.

  • September 18, 2026

    Mass. Court Upholds Troopers' Firings Under Vax Order

    Massachusetts' intermediate appellate court on Friday affirmed the firings of 13 state police troopers who failed to get COVID-19 vaccinations in 2021, finding that disciplinary decisions were not subject to an arbitration clause in their union contract.

  • September 18, 2026

    SEIU Seeks Early Win In Immigrant Worker Access Dispute

    The Service Employees International Union and four Boston airport workers have asked a Massachusetts federal court to bar the Trump administration from revoking security clearances that allowed immigrants to work in airport terminals, claiming the policy change was arbitrary and capricious.

  • September 18, 2026

    Injured Sprinter Says Puma Trying End-Run In German Court

    An athlete alleging she was injured by Puma's carbon fiber shoes has told a Massachusetts state court the brand's U.S. subsidiary should be barred from pursuing a $13.3 million de facto counterclaim in a German court, calling it an attempt to "intimidate" her and other runners pursuing product liability cases against the company.

  • September 18, 2026

    Mass. High Court Again Upholds Housing Density Law

    A controversial law that requires towns served by the Boston metro area's public transit system to allow greater housing density survived another legal challenge Friday, as Massachusetts' highest court affirmed the measure does not conflict with the state constitution.

  • September 17, 2026

    Judge Nixes DEI Conditions For Federal Education Funds

    A Massachusetts federal judge Thursday found the U.S. Office of Management and Budget cannot stipulate education research funding on rooting out diversity, equity and inclusion initiatives, but declined to force the government to spend certain education funds before they expire this month.

  • September 17, 2026

    Broker TradeZero Fined Over Data Breach Tied To Chatbot

    An unvetted chatbot and lax security policies allowed hackers to access personal and financial information of nearly 15,000 customers of online brokerage TradeZero America, the Massachusetts Securities Division said Thursday in announcing a $750,000 fine against the company.

  • September 17, 2026

    Ore. Judge Denies HHS' Attempt To Amend Gender Care Order

    An Oregon federal judge on Thursday rejected the Trump administration's bid to narrow an earlier order that voided a policy declaration central to the government's crackdown on gender-affirming care for minors.

  • September 17, 2026

    GE Vernova, Vineyard Wind Drop Dispute Over Payment

    Vineyard Wind I LLC and a GE Vernova subsidiary have dropped their legal dispute over a $300,000 bill for work on turbines off the Massachusetts coast, according to Wednesday court filings.

  • September 17, 2026

    Full Fed. Circ. Won't Rethink Pfizer's Paxlovid IP Win

    The full Federal Circuit on Thursday won't disturb a panel's refusal to revive a patent that Enanta Pharmaceuticals had accused Pfizer of infringing through its blockbuster Paxlovid COVID-19 treatment.

  • September 17, 2026

    Clancy Atty Denies Malpractice Claim By Man Serving Life

    A prominent Massachusetts criminal defense attorney best known for representing Lindsay Clancy has been accused in a separate case of "abandoning" a client who is serving life sentences for second-degree murder and home invasion, allegations the lawyer denies.

  • September 17, 2026

    Cruz, Markey Urge Senate To Pass Bill On AM Radio In Cars

    Senate Commerce Committee Chairman Ted Cruz, R-Texas, and Sen. Edward J. Markey, D-Mass., have called on the Senate to advance the AM Radio for Every Vehicle Act following its passage in the House of Representatives.

  • September 17, 2026

    1st Circ. Lets HUD Shift $1.3B In Homelessness Aid

    A First Circuit panel said the U.S. Department of Housing and Urban Development may redirect $1.3 billion in homelessness funding from programs that focus on permanent housing to those supporting temporary shelter and assistance, finding the Trump administration likely was not required to go through a notice-and-comment procedure.

  • September 17, 2026

    Republicans Move Trump's CFPB Pick Ahead To Full Senate

    President Donald Trump's latest pick to lead the Consumer Financial Protection Bureau moved closer to confirmation Thursday as Republican lawmakers voted to advance his nomination to the U.S. Senate floor.

  • September 16, 2026

    Birkenstock Rival Can't Stomp Out Shoe IP Suit Before Trial

    A Massachusetts federal judge refused Wednesday to grant White Mountain a partial win on Birkenstock's infringement claims in a fight over shoe designs, finding that there are too many factual disputes to determine on summary judgment whether Birkenstock waited too long to sue, so the case must be tried.

  • September 16, 2026

    New Balance Sues Decathlon Over Kiprun Sneakers 'K' Design

    New Balance hit Decathlon America LLC with a trademark infringement lawsuit over a new line of Kiprun running shoes, with the Boston-based company telling a Massachusetts federal court that the Kiprun design is "virtually identical" to the famous "N" New Balance logo.

  • September 16, 2026

    Software Execs Sank Nike Deal Before Joining Rival, Suit Says

    Event software company JRNI Inc. says two former executives conspired to steer its biggest client, Nike, to a rival, then left to join that competitor, according to a complaint filed Tuesday in Massachusetts state court. 

  • September 16, 2026

    1st Circ. Seems Torn Over Health Plan Surcharge For Smokers

    A First Circuit panel appeared divided Wednesday over whether a casino company is required to refund tobacco use fees after smokers on the company's health plan complete a tobacco cessation program.

  • September 16, 2026

    1st Circ. Won't Upend City's Win In Firefighters' Bias Dispute

    The First Circuit on Wednesday upheld a jury's verdict in favor of Springfield, Massachusetts, in a suit brought by two Black firefighters who claimed the city stymied advancement opportunities because of their bias complaints, saying it found no issue with the way the lower court handled the trial.

  • September 16, 2026

    Contractor, Defense Agency Reach Ch. 11 Claim Setoff Deal

    Bankrupt government defense contractor Noble Supply & Logistics LLC reached a short-term deal with the Defense Logistics Agency on Wednesday in Delaware court that will allow for the agency to make contractual payments to the debtor as it pursues a Chapter 11 asset sale.

  • September 16, 2026

    1st Circ. Hints Trump Admin Sought To Skirt Review Of Cuts

    The First Circuit on Wednesday repeatedly suggested that the Trump administration had sought to evade court review by intentionally failing to issue written guidance before it began shuttering federal programs targeted by the president in an executive order last year.

  • September 16, 2026

    Muscular Dystrophy Drug Co. Beats Investor Suit Over Risks

    A Massachusetts federal judge denied investors another chance to rework their suit accusing Sarepta Therapeutics and its executives of misleading the market about the safety and efficacy of their muscular dystrophy treatments, saying it fails to show they knew about issues with the products and trials when they made certain statements.

  • September 16, 2026

    States Say DOJ's RealPage Deal Doesn't Affect Their Claims

    A group of states told a North Carolina federal court to reject property management software company RealPage Inc.'s argument that its rent price-fixing settlement with the federal government moots the states' antitrust claims.

Expert Analysis

  • Rhode Island Self-Checkout Law Signals National Trend

    Author Photo

    Rhode Island's law limiting self-checkout in retail stores is the first of its kind, but state and local lawmakers across the country are considering similar bills — and if enacted, they could create a patchwork of compliance requirements around issues including staffing, signage and restricted merchandise, says Hannah Flint at Hunton.

  • Series

    Being A Singer Makes Me A Better Lawyer

    Author Photo

    Before law school, I spent seven years trying to make it as a professional singer in Los Angeles, and nearly everything I learned about preparation, humility, confidence and more has followed me into my legal practice, says Jessica Caterina at Moses & Singer.

  • Mass. UHC Fraud Suit Signals States' Medicaid FCA Push

    Author Photo

    Massachusetts' recently filed False Claims Act suit alleging UnitedHealthcare misrepresented the health status of enrollees in a Medicaid senior care organization plan it managed pushes forward a new phase of state-level scrutiny of managed care data and Medicaid payment mechanisms, say Li Yu at Bernstein Litowitz, Ellen London at London & Naor and Gwendolyn Stamper at Vogel Slade.

  • The Growing Antitrust Risks Of AI Pricing For Health Insurers

    Author Photo

    Attorneys at Patterson Belknap provide an overview of the increased risk of antitrust enforcement for health insurance companies using algorithmic price models, including in the form of multidistrict private litigation, new state and federal bills, and potential federal enforcement.

  • Solar's Momentum At Mid-2026 Will Help It Overcome Snags

    Author Photo

    The rapid expansion of U.S. solar development in the first half of 2026 is likely to continue its pace, even amid ongoing shifts in federal trade policy and supply chain regulations, obstacles to permitting reform, and an increasing divide between states enacting policies to encourage or stymie project development, say attorneys at Beveridge & Diamond.

  • Series

    Being A Magician Makes Me A Better Lawyer

    Author Photo

    The skills I've developed as a lifelong magician have translated directly into tangible benefits in the courtroom because performing magic and trying cases both live at the intersection of psychology, storytelling, timing and disciplined rehearsal, says Mark Dombroff at Fox Rothschild.

  • How Pfizer Won Fed. Circ. Patent Dispute By 1 Carbon Atom

    Author Photo

    The Federal Circuit's recent refusal to revive a patent in Enanta Pharmaceuticals v. Pfizer over an alleged typo creating a one-atom difference in a COVID-19 treatment application hands defendants a template for potentially converting a triable fact question into an early dispositive ruling, say attorneys at Polsinelli.

  • Laptop Farms Highlight Identity Fraud Risks Of Remote Work

    Author Photo

    Two U.S. nationals' recent sentencing in Massachusetts federal court for a scheme that enabled foreign operatives to obtain remote jobs at U.S. companies using stolen identities is a reminder that employers must recalibrate their remote hiring, onboarding and monitoring practices to mitigate evolving cybersecurity and geopolitical risks, say attorneys at Foley & Lardner.

  • Series

    Bass Fishing Makes Me A Better Lawyer

    Author Photo

    Landing a trophy striped bass and closing a big deal both require cultivating the patience to finesse — not force — your way to desired outcomes, changing course when your old approach isn’t working and learning from the ones that got away, says Jon Ruiss at Alston & Bird.

  • Roundup

    The Most Talked-About Supreme Court Decisions Of 2026

    Author Photo

    This term, 11 U.S. Supreme Court decisions quickly became hot topics among Law360's guest writers.

  • Immigration Ruling Maps Alternative To Universal Injunctions

    Author Photo

    A Rhode Island federal court's decision in Dorcas International Institute of Rhode Island v. USCIS vacating policies that froze key immigration adjudications for nationals of 39 countries, and paused asylum applications altogether, suggests how practitioners might press for the Administrative Procedure Act's bad faith exception to record review and seek vacatur as a viable alternative to universal injunctions, says Kemal Hepsen at Mandamus Lawyers.

  • Series

    Choral Singing Makes Me A Better Lawyer

    Author Photo

    Singing in the New York City Bar Chorus — a hobby partly inspired by the late U.S. District Judge Richard Owen, who infused my clerkship year with opera music — has improved my legal career by refining my abilities to listen, exude confidence and develop emotional intelligence, says Bonnie Baker at Friedman Kaplan.

  • Attorney Mental Health Is An Ethical Obligation In The AI Era

    Author Photo

    As attorneys cope with the increasing unpredictability that artificial intelligence and constant policy changes have created, particularly in practice areas where they carry the emotional weight of clients’ most consequential life events, otherwise soft discussions about self-care are a matter of professional competence, says attorney Jack Jrada.

  • Key Tips For Patenting Antibody-Drug Conjugate Inventions

    Author Photo

    Recent decisions highlight the significant challenges that can arise when patenting antibody-drug conjugates, which require strategic considerations for satisfying heightened written description and enablement requirements, says Xiaoban Xin at FisherBroyles.

  • $885M IBS Drug Verdict Tests Pay-For-Delay Limits

    Author Photo

    The outcome in the Amitiza Antitrust Litigation is significant because it is the first jury trial win for private antitrust plaintiffs in a suit challenging a patent settlement reverse payment since the U.S. Supreme Court adopted the rule-of-reason legal framework in 2013, offering a blueprint for pay-for-delay claims, say attorneys at Katten.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Massachusetts archive.